These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8849765)

  • 1. Monitoring the performance of breast screening programmes: allowing for geographical variation in breast cancer incidence.
    Blanks RG; Moss SM
    J Med Screen; 1996; 3(2):82-4. PubMed ID: 8849765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring the performance of breast screening programmes: use of indirect standardisation in evaluating the invasive cancer detection rate.
    Blanks RG; Day NE; Moss SM
    J Med Screen; 1996; 3(2):79-81. PubMed ID: 8849764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of cancer detection rates achieved by breast cancer screening programmes by number of readers, for one and two view mammography: results from the UK National Health Service breast screening programme.
    Blanks RG; Wallis MG; Moss SM
    J Med Screen; 1998; 5(4):195-201. PubMed ID: 9934650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring and evaluating the UK National Health Service Breast Screening Programme: evaluating the variation in radiological performance between individual programmes using PPV-referral diagrams.
    Blanks RG; Moss SM; Wallis MG
    J Med Screen; 2001; 8(1):24-8. PubMed ID: 11373846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer detection rates, and standardised detection ratios for prevalence screening in the New Zealand breast cancer screening programme.
    Richardson A; Graham P; Brown T; Smale P; Cox B
    J Med Screen; 2004; 11(2):65-9. PubMed ID: 15153320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results from the UK NHS breast screening programme 1994-1999.
    Blanks RG; Moss SM; Patnick J
    J Med Screen; 2000; 7(4):195-8. PubMed ID: 11202586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of two view and one view mammography in the detection of small invasive cancers: results from the National Health Service breast screening programme.
    Blanks RG; Moss SM; Wallis MG
    J Med Screen; 1996; 3(4):200-3. PubMed ID: 9041485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time trends of process and impact indicators in Italian breast screening programmes--1996-2005.
    Giordano L; Giorgi D; Piccini P; Ventura L; Stefanini V; Senore C; Paci E; Segnan N
    Epidemiol Prev; 2008; 32(2 Suppl 1):23-36. PubMed ID: 18770993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring interval cancers in breast screening programmes: the east Anglian experience. Quality Assurance Management Group of the East Anglian Breast Screening Programme.
    Day N; McCann J; Camilleri-Ferrante C; Britton P; Hurst G; Cush S; Duffy S
    J Med Screen; 1995; 2(4):180-5. PubMed ID: 8719145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National Health Service breast screening programme results for 1991-2.
    Chamberlain J; Moss SM; Kirkpatrick AE; Michell M; Johns L
    BMJ; 1993 Aug; 307(6900):353-6. PubMed ID: 8374416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing the performance of mammography screening in the USA and the UK.
    Smith-Bindman R; Ballard-Barbash R; Miglioretti DL; Patnick J; Kerlikowske K
    J Med Screen; 2005; 12(1):50-4. PubMed ID: 15814020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pooled analysis of interval cancer rates in six European countries.
    Törnberg S; Kemetli L; Ascunce N; Hofvind S; Anttila A; Sèradour B; Paci E; Guldenfels C; Azavedo E; Frigerio A; Rodrigues V; Ponti A
    Eur J Cancer Prev; 2010 Mar; 19(2):87-93. PubMed ID: 20010429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer in East Anglia: the impact of the breast screening programme on stage at diagnosis.
    McCann J; Stockton D; Day N
    J Med Screen; 1998; 5(1):42-8. PubMed ID: 9575460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calculating appropriate target cancer detection rates and expected interval cancer rates for the UK NHS Breast Screening Programme. Interval Cancer Working Group.
    Moss S; Blanks R
    J Epidemiol Community Health; 1998 Feb; 52(2):111-5. PubMed ID: 9578858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mammography breast cancer screening in Italy: 2010 survey].
    Giorgi D; Giordano L; Ventura L; Frigerio A; Paci E; Zappa M
    Epidemiol Prev; 2012; 36(6 Suppl 1):8-27. PubMed ID: 23293268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of issuing an invitation for breast cancer screening to women aged 65 to 69.
    Hendry PJ; Entwistle C
    J Med Screen; 1996; 3(2):88-9. PubMed ID: 8849767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of organised screening programmes on the stage-specific incidence of breast cancer in some Italian areas.
    Buiatti E; Barchielli A; Bartolacci S; Federico M; De Lisi V; Bucchi L; Ferretti S; Paci E; Segnan N; Tumino R;
    Eur J Cancer; 2003 Aug; 39(12):1776-82. PubMed ID: 12888374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does individual programme size affect screening performance? Results from the United Kingdom NHS breast screening programme.
    Blanks RG; Bennett RL; Wallis MG; Moss SM
    J Med Screen; 2002; 9(1):11-4. PubMed ID: 11943791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of screening mammography in the United States and the United kingdom.
    Smith-Bindman R; Chu PW; Miglioretti DL; Sickles EA; Blanks R; Ballard-Barbash R; Bobo JK; Lee NC; Wallis MG; Patnick J; Kerlikowske K
    JAMA; 2003 Oct; 290(16):2129-37. PubMed ID: 14570948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results from the NHS breast screening programme 1990-1993.
    Moss SM; Michel M; Patnick J; Johns L; Blanks R; Chamberlain J
    J Med Screen; 1995; 2(4):186-90. PubMed ID: 8719146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.